Vaccine News and Research

Latest Vaccine News and Research

COVID-19 vaccine tracker provides real-time updates on effective vaccine

McGill University professor Nicole Basta and her team have created an interactive online COVID-19 vaccine tracker, that provides real-time updates on progress in developing a safe and effective vaccine.

27 Oct 2020

Researchers identify effective way to protect vulnerable people from COVID-19

T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus's function, according to a new study published Oct. 26 in Blood.

27 Oct 2020

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.

26 Oct 2020

Research uncovers SARS-CoV-2 viral traits critical for the virus in human airways

A new study published on the preprint server bioRxiv* in October 2020 reports the discovery of important viral genomic features that are crucial to its replication in the human airway cells, and its enhancing mutations which increase the rate of replication and determine its target cells.

26 Oct 2020

Scientists devise new method to map HIV's sugary shield in unprecedented detail

Scientists from Scripps Research and Los Alamos National Laboratory have devised a method for mapping in unprecedented detail the thickets of slippery sugar molecules that help shield HIV from the immune system.

23 Oct 2020

Mathematical modeling study offers new insights into optimal timing of antiviral therapies against COVID-19

A new mathematical modeling study by Ashish Goyal and colleagues, informed by data collected from 25 patients hospitalized with COVID-19 in 4 different countries, offers some important new insights into the optimal timing of 4 different antiviral therapies to combat the disease.

23 Oct 2020

COVID-19 pandemic has escalated into a ‘syndemic’ for chronic disease patients

The COVID-19 pandemic has escalated into a ‘syndemic’ for people with chronic illnesses, a new UNSW study analysing data from low and middle-income countries shows.

23 Oct 2020

ACROBiosystems and the Fight Against COVID-19

In this interview, Dr. Yinang Jiang discusses ACROBiosystems and their efforts in the fight against COVID-19 and the search for a vaccine

From ACROBiosystems 23 Oct 2020

Travel on Thanksgiving? Pass the COVID

Molly Wiese was truly stumped. Her parents and siblings live in Southern California, and Wiese, a 35-year-old lawyer, has returned home every Christmas since she moved to Minnesota in 2007.

23 Oct 2020

Nigeria safely relaunches accelerated yellow fever vaccination campaigns

While combatting multiple public health challenges, including the COVID-19 pandemic, the Government of Nigeria, with support of the World Health Organization (WHO) and Gavi, the Vaccine Alliance will safely relaunch an accelerated series of mass preventive vaccination campaigns to protect Nigerians against yellow fever (YF).

23 Oct 2020

Preventive antimalarial treatments drastically reduce malaria infections among school children

With nearly half of the world's population at risk for life-threatening malaria infections, University of Maryland School of Medicine (UMSOM) researchers and their colleagues identified an important public health measure to control the disease.

23 Oct 2020

New research may shed light on challenges of developing universal flu vaccine

New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against influenza viruses.

23 Oct 2020

Researchers develop a novel method to test for COVID-19 antibodies

When Dr. Stephen Smith of Seattle Children's Research Institute came down with muscle aches, gastrointestinal distress and a sudden loss of smell in late February, he suspected he had COVID-19.

23 Oct 2020

Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels

A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.

23 Oct 2020

Researchers use viral signatures to reveal transmission patterns of SARS-CoV-2

The coronavirus, responsible for the COVID-19 pandemic, has one official name--SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus.

23 Oct 2020

DNA vaccine-induced antibodies neutralize SARS-CoV-2

The coronavirus disease (COVID-19) is far from over as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage across the globe. With the vast spread of the virus, many countries who reported flattening the curve over the past months have reported clusters of new cases and second waves of the outbreak.

22 Oct 2020

$2 million NCI SeroNet grant aims to increase diversity in COVID-19 immunology research

A new, $2 million grant from the NCI Serological Sciences Network for COVID-19 (SeroNet) is aimed at enhancing representation of Black and Hispanic people in SARS-CoV-2 immunology research through the use of storytelling--an approach in which community members become "video stars" and provide honest messages about the importance of being represented in COVID-19 research studies.

22 Oct 2020

Study may pave way for more effective treatment for Hepatitis C

Virologists at Institut national de la recherche scientifique (INRS) have identified a critical role played by a cellular protein in the progression of Hepatitis C virus infection, paving the way for more effective treatment.

22 Oct 2020

Study reveals factors that account for reduced death rates from COVID-19

Fewer New Yorkers are dying from the coronavirus than health experts had anticipated, a new study shows. Regional death rates have dropped from the highs seen at the start of the outbreak, partially due to a shift in the population contracting the disease toward those who are more resilient.

22 Oct 2020

Study shows how genome sequencing can track mutations in SARS-CoV-2 virus

A study published in Cell Reports shows how next generation genetic sequencing can track mutations in the SARS-CoV-2 virus, which can in effect help with transmission tracing, diagnostic testing accuracy and vaccine effectiveness.

22 Oct 2020